← Leaderboards
Konstantin V Korotkov
University Of Kentucky
$3,335,048
Attributed
$4,982,970
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,982,970 · 6
By mechanism
R01$3,832,412 · 2
R21$847,099 · 2
R03$303,459 · 2
Top collaborators
- John D Buynak3 shared
- Kyle H Rohde3 shared
- Katy Patras2 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Katy Patras$3,395,851
- Natalia Korotkova$5,800,967
Others in their field
Top investigators on “Pathogen”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$343,790,695
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
- Jeffrey P Krischer · University Of South Florida$130,496,919
- Mark S Klempner · Tufts Medical Center$128,021,180
- Timothy Stedman · American Type Culture Collection$122,230,581
- Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai$99,962,183
Research focus
PathogenProteinsInfectionPathway InteractionsIn VitroBiochemicalCell WallDesignInsightPlayComplexVirulenceFutureEnzymesIn VivoMycobacterialAnabolismMycobacterium TuberculosisResistant StrainAntibioticsDrug DiscoveryBiologicalGeneticGenus Mycobacterium
Grant awards (16)
Optimization of Atypical Antimycobacterial Carbapenem Antibiotics$681,269
R01 · FY2025 · AI
Optimization of Atypical Antimycobacterial Carbapenem Antibiotics$698,616
R01 · FY2024 · AI
Function of the type 7 secretion system in Group B Streptococcus$195,543
R21 · FY2024 · AI · contact PI
Optimization of Atypical Antimycobacterial Carbapenem Antibiotics$759,402
R01 · FY2023 · AI
Function of the type 7 secretion system in Group B Streptococcus$247,918
R21 · FY2023 · AI · contact PI
Functional Role of the Enterococcal Polysaccharide Antigen$191,250
R21 · FY2023 · AI · contact PI
Functional Role of the Enterococcal Polysaccharide Antigen$212,388
R21 · FY2022 · AI · contact PI
Novel therapeutic approaches for treatment of drug-resistant Gram-positive infections$76,500
R03 · FY2022 · AI · contact PI
Novel therapeutic approaches for treatment of drug-resistant Gram-positive infections$76,500
R03 · FY2021 · AI · contact PI
Structure and mechanism of the ESX secretion system from pathogenic mycobacteria$376,250
R01 · FY2019 · AI · contact PI
Structure and mechanism of the ESX secretion system from pathogenic mycobacteria$376,250
R01 · FY2018 · AI · contact PI
Structure and mechanism of the ESX secretion system from pathogenic mycobacteria$376,250
R01 · FY2017 · AI · contact PI
Structure and mechanism of the ESX secretion system from pathogenic mycobacteria$376,250
R01 · FY2016 · AI · contact PI
Targeting NAD biosynthesis in Mycobacterium tuberculosis$75,250
R03 · FY2016 · AI · contact PI
Structure and mechanism of the ESX secretion system from pathogenic mycobacteria$188,125
R01 · FY2015 · AI · contact PI
Targeting NAD biosynthesis in Mycobacterium tuberculosis$75,209
R03 · FY2015 · AI · contact PI